Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

TSX:ALS - Toronto Stock Exchange - CA0209361009 - Common Stock - Currency: CAD

29.88  -0.02 (-0.07%)

Fundamental Rating

6

ALS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 797 industry peers in the Metals & Mining industry. ALS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ALS had positive earnings in the past year.
ALS had a positive operating cash flow in the past year.
Of the past 5 years ALS 4 years were profitable.
ALS had a positive operating cash flow in each of the past 5 years.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of ALS (14.22%) is better than 94.86% of its industry peers.
With an excellent Return On Equity value of 17.89%, ALS belongs to the best of the industry, outperforming 94.10% of the companies in the same industry.
The Return On Invested Capital of ALS (2.54%) is better than 90.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALS is significantly below the industry average of 11.45%.
Industry RankSector Rank
ROA 14.22%
ROE 17.89%
ROIC 2.54%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 179.75%, ALS belongs to the top of the industry, outperforming 99.25% of the companies in the same industry.
ALS's Profit Margin has improved in the last couple of years.
ALS's Operating Margin of 48.00% is amongst the best of the industry. ALS outperforms 98.75% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
ALS has a better Gross Margin (88.88%) than 99.75% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 48%
PM (TTM) 179.75%
GM 88.88%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALS is destroying value.
Compared to 1 year ago, ALS has less shares outstanding
ALS has more shares outstanding than it did 5 years ago.
ALS has a worse debt/assets ratio than last year.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.04 indicates that ALS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.04, ALS is in the better half of the industry, outperforming 66.62% of the companies in the same industry.
ALS has a debt to FCF ratio of 4.41. This is a neutral value as ALS would need 4.41 years to pay back of all of its debts.
The Debt to FCF ratio of ALS (4.41) is better than 91.34% of its industry peers.
ALS has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ALS has a Debt to Equity ratio of 0.17. This is in the lower half of the industry: ALS underperforms 66.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.41
Altman-Z 6.04
ROIC/WACC0.3
WACC8.56%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.91 indicates that ALS has no problem at all paying its short term obligations.
The Current ratio of ALS (2.91) is better than 62.48% of its industry peers.
A Quick Ratio of 2.91 indicates that ALS has no problem at all paying its short term obligations.
The Quick ratio of ALS (2.91) is better than 64.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.91
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.17% over the past year.
The earnings per share for ALS have been decreasing by -13.58% on average. This is quite bad
Looking at the last year, ALS shows a decrease in Revenue. The Revenue has decreased by -5.50% in the last year.
The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)4.17%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-9.27%

3.2 Future

ALS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.69% yearly.
ALS is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -21.40% yearly.
EPS Next Y15.96%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
EPS Next 5Y17.69%
Revenue Next Year-10.06%
Revenue Next 2Y2.95%
Revenue Next 3Y2.51%
Revenue Next 5Y-21.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 119.52, which means the current valuation is very expensive for ALS.
Compared to the rest of the industry, the Price/Earnings ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 86.20% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.54, ALS is valued quite expensively.
ALS is valuated quite expensively with a Price/Forward Earnings ratio of 69.77.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 85.70% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.28. ALS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 119.52
Fwd PE 69.77
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

87.95% of the companies in the same industry are more expensive than ALS, based on the Enterprise Value to EBITDA ratio.
90.72% of the companies in the same industry are more expensive than ALS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 57.95
EV/EBITDA 44.63
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALS does not grow enough to justify the current Price/Earnings ratio.
ALS has an outstanding profitability rating, which may justify a higher PE ratio.
ALS's earnings are expected to grow with 23.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.49
PEG (5Y)N/A
EPS Next 2Y25.94%
EPS Next 3Y23.48%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.24%, ALS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 16.93, ALS pays a better dividend. On top of this ALS pays more dividend than 96.61% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, ALS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

14.77% of the earnings are spent on dividend by ALS. This is a low number and sustainable payout ratio.
ALS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP14.77%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (8/7/2025, 7:00:00 PM)

29.88

-0.02 (-0.07%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11
Inst Owners19.64%
Inst Owner ChangeN/A
Ins Owners5.35%
Ins Owner ChangeN/A
Market Cap1.38B
Analysts78.18
Price Target34.53 (15.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP14.77%
Div Incr Years4
Div Non Decr Years4
Ex-Date05-30 2025-05-30 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.23%
Min EPS beat(2)-29.28%
Max EPS beat(2)18.81%
EPS beat(4)1
Avg EPS beat(4)-13.28%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-19.14%
EPS beat(12)2
Avg EPS beat(12)-21.93%
EPS beat(16)3
Avg EPS beat(16)-14.53%
Revenue beat(2)0
Avg Revenue beat(2)-8.45%
Min Revenue beat(2)-11.56%
Max Revenue beat(2)-5.33%
Revenue beat(4)1
Avg Revenue beat(4)-5.19%
Min Revenue beat(4)-15.78%
Max Revenue beat(4)11.92%
Revenue beat(8)2
Avg Revenue beat(8)-8.23%
Revenue beat(12)4
Avg Revenue beat(12)-5.29%
Revenue beat(16)5
Avg Revenue beat(16)-4.14%
PT rev (1m)1.07%
PT rev (3m)1.94%
EPS NQ rev (1m)-46.67%
EPS NQ rev (3m)-48.93%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-14.86%
Revenue NQ rev (3m)-14%
Revenue NY rev (1m)-4.24%
Revenue NY rev (3m)-4.24%
Valuation
Industry RankSector Rank
PE 119.52
Fwd PE 69.77
P/S 24.33
P/FCF 57.95
P/OCF 51.98
P/B 2.42
P/tB 2.42
EV/EBITDA 44.63
EPS(TTM)0.25
EY0.84%
EPS(NY)0.43
Fwd EY1.43%
FCF(TTM)0.52
FCFY1.73%
OCF(TTM)0.57
OCFY1.92%
SpS1.23
BVpS12.34
TBVpS12.34
PEG (NY)7.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.22%
ROE 17.89%
ROCE 3.84%
ROIC 2.54%
ROICexc 2.58%
ROICexgc 2.58%
OM 48%
PM (TTM) 179.75%
GM 88.88%
FCFM 41.99%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexcg growth 3Y-14.71%
ROICexcg growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.41
Debt/EBITDA 2.94
Cap/Depr 47.17%
Cap/Sales 4.83%
Interest Coverage 3.42
Cash Conversion 80.39%
Profit Quality 23.36%
Current Ratio 2.91
Quick Ratio 2.91
Altman-Z 6.04
F-Score5
WACC8.56%
ROIC/WACC0.3
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.17%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-28.57%
EPS Next Y15.96%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
EPS Next 5Y17.69%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-9.27%
Revenue Next Year-10.06%
Revenue Next 2Y2.95%
Revenue Next 3Y2.51%
Revenue Next 5Y-21.4%
EBIT growth 1Y4.92%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year55.21%
EBIT Next 3Y28.31%
EBIT Next 5Y19.49%
FCF growth 1Y-61.2%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-57.69%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%